{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:28:27Z","timestamp":1765826907874},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.surg.2009.10.061","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T08:53:23Z","timestamp":1261040003000},"page":"704-712","source":"Crossref","is-referenced-by-count":13,"title":["Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models"],"prefix":"10.1016","volume":"147","author":[{"given":"Christina","family":"Hackl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven A.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Dayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Hellerbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Stoeltzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2009.10.061_bib1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","article-title":"Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer","volume":"26","author":"Gruenberger","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"6 Suppl. 9","key":"10.1016\/j.surg.2009.10.061_bib3","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1053\/j.seminoncol.2005.04.030","article-title":"Making unresectable hepatic colorectal metastases resectable\u2013does it work?","volume":"32","author":"Vauthey","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1245\/s10434-009-0447-z","article-title":"Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab","volume":"16","author":"Aussilhou","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib5","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1200\/JCO.2008.17.7857","article-title":"Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases","volume":"26","author":"Kesmodel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejso.2007.07.007","article-title":"Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases","volume":"34","author":"Morris-Stiff","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.gassur.2003.08.005","article-title":"Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy","volume":"7","author":"Parikh","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2009.10.061_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/ASO.2003.07.019","article-title":"Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis","volume":"10","author":"Stoeltzing","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/156800908785699379","article-title":"The heat shock protein 90 chaperone complex: an evolving therapeutic target","volume":"8","author":"Barginear","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.surg.2009.10.061_bib10","first-page":"2478","article-title":"Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells","volume":"62","author":"Mabjeesh","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib11","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1158\/1535-7163.MCT-07-0410","article-title":"Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo","volume":"6","author":"Moser","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.surg.2009.10.061_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00109-004-0549-9","article-title":"Targeting multiple signal transduction pathways through inhibition of Hsp90","volume":"82","author":"Zhang","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.surg.2009.10.061_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","article-title":"Heat shock protein 90 as a molecular target for cancer therapeutics","volume":"3","author":"Isaacs","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.surg.2009.10.061_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00001622-200311000-00003","article-title":"Heat shock protein 90","volume":"15","author":"Neckers","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib15","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1158\/1078-0432.CCR-03-0795","article-title":"Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator","volume":"10","author":"Kaur","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/1535-7163.MCT-05-0439","article-title":"Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis","volume":"5","author":"Sanderson","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.surg.2009.10.061_bib17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.2005.09.119","article-title":"Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer","volume":"23","author":"Goetz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2009.10.061_bib18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-06-2233","article-title":"Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers","volume":"13","author":"Ramanathan","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib19","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1158\/1078-0432.CCR-08-1002","article-title":"Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma","volume":"14","author":"Solit","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib20","first-page":"53","article-title":"The involvement of heat shock proteins in murine liver regeneration","volume":"4","author":"Shi","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.surg.2009.10.061_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/bjs.1800801104","article-title":"Hepatocyte growth factor\/scatter factor, liver regeneration and cancer metastasis","volume":"80","author":"Jiang","year":"1993","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2009.10.061_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0168-8278(01)00081-2","article-title":"Vascular endothelial growth factor and liver regeneration","volume":"34","author":"Reynaert","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2009.10.061_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1026392429112","article-title":"Charitable state-controlled foundation human tissue and cell research: ethic and legal aspects in the supply of surgically removed human tissue for research in the academic and commercial sector in Germany","volume":"4","author":"Thasler","year":"2003","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.surg.2009.10.061_bib24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.105.094201","article-title":"Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration","volume":"316","author":"Thasler","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.surg.2009.10.061_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0168-8278(02)00454-3","article-title":"Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid","volume":"38","author":"Weiss","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2009.10.061_bib26","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-07-1104","article-title":"Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6\/signal-transducer and activator of transcription 3\/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth","volume":"13","author":"Lang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08941930490502871","article-title":"A model of partial hepatectomy in mice","volume":"17","author":"Nikfarjam","year":"2004","journal-title":"J\u00a0Invest Surg"},{"key":"10.1016\/j.surg.2009.10.061_bib28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1535-7163.MCT-06-0628","article-title":"Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo","volume":"6","author":"Lang","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.surg.2009.10.061_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.22685","article-title":"Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice","volume":"49","author":"Lang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.surg.2009.10.061_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ccr.2008.08.002","article-title":"Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis","volume":"14","author":"Powers","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.surg.2009.10.061_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2009.10.061_bib32","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.1158\/0008-5472.CAN-05-1799","article-title":"Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2009.10.061_bib33","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcb.20348","article-title":"Transactivation of hsp70-1\/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C","volume":"94","author":"Shu","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.surg.2009.10.061_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10620-008-0372-1","article-title":"Genetic recombinant expression and characterization of human augmenter of liver regeneration","volume":"54","author":"Gao","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.surg.2009.10.061_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s005350050023","article-title":"Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases","volume":"35","author":"Tanigawa","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.surg.2009.10.061_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2559.2005.02172.x","article-title":"Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma","volume":"47","author":"Thasler","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.surg.2009.10.061_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI116332","article-title":"Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration","volume":"91","author":"Haber","year":"1993","journal-title":"J Clin Invest"},{"issue":"2 Suppl 1","key":"10.1016\/j.surg.2009.10.061_bib38","first-page":"S45","volume":"43","author":"Fausto","year":"2006","journal-title":"Liver regeneration. Hepatology"},{"key":"10.1016\/j.surg.2009.10.061_bib39","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1128\/MCB.02253-05","article-title":"Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection","volume":"26","author":"Bard-Chapeau","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.surg.2009.10.061_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606009006965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606009006965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T09:24:22Z","timestamp":1544779462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606009006965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0039606009006965"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2009.10.061","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}